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Background: Population-based breast cancer screening programs were implemented to reduce breast cancer
mortality and to improve recovery chances. Breast cancer screening participation among migrant women differs
from that of autochthonous populations in several European countries. Here we investigate for the first time
participation among women of Turkish origin in Germany.
Methods: Data of five screening units covering 2010 and 2011 as well as associated population registries were
analysed. Women of Turkish origin were identified using a name-based algorithm. Participation ratios among
women of Turkish origin and odds ratios compared to women of non-Turkish origin were calculated. Analyses were
stratified and adjusted for age-groups and screening unit.
Results: A total of 208,500 participants in the five breast screening units were included, out of 423,649 eligible
women in the catchment areas (participation 49.2%). Women of Turkish origin have a slightly higher chance to
participate in breast cancer screening than women without Turkish origin (OR 1.17; 95% CI: 1.14-1.21). Only women
of Turkish origin aged 65–69 years have a lower chance to participate than women without Turkish origin (OR: 0.71;
95% CI: 0.66-0.75).
Conclusion: In spite of low participation in preventive measures among migrant populations, the overall breast
cancer screening participation among women of Turkish origin in Germany seems to be higher compared to
women of non-Turkish origin. Turkish women aged 65 years and above have a lower chance of participation than
younger Turkish women. There is need for further research to study factors affecting participation in screening
among migrant and non-migrant populations in Germany.
Keywords: Breast cancer screening, Mammography, Participation, Use, Uptake, Attendance, Immigrants, Turks,
Germany, Name-based identificationBackground
Breast cancer is the most common cancer among women
world-wide [1]. In Europe, there were 331,000 breast can-
cer cases in 2006, accounting for 30 percent of all cancer
cases among women; with approximately 90,000 deaths in
2006, breast cancer is the second most common cause of
death among women in Europe [2]. Based on European
guidelines, population-based breast cancer screening pro-
grams were implemented in most countries to reduce* Correspondence: eva-maria.berens@uni-bielefeld.de
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reproduction in any medium, provided the orbreast cancer mortality and start treatment earlier and
thus to enhance recovery chances [3].
In Germany, a nationwide population-based breast
cancer screening program was implemented from 2005
onwards [4]. Implementation has been completed in
2009 and about 10 million women between the ages of
50 and 69 years are served by 94 screening units.
Women in the eligible age group are invited by mail to
undergo a mammography in the specialised screening
unit in their area of residence every other year [5]. By
2009, more than half (54.4 percent) of the women offi-
cially invited actually participated in the breast cancer
screening program (this figure includes some whoLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reached them). The European guidelines recommend a
participation ratio of at least 70 percent to ensure effect-
iveness of the screening program [3]. In 2005–2006, a
slightly larger proportion of women participated (57.3
percent) than in 2007 (53.6 percent) [5]. There are large
regional differences in screening participation: In the
federal states of Bavaria and Schleswig-Holstein, 45.4
percent of the eligible women attended the screening in
2009 while in Saxony, Bremen, Saxony-Anhalt and
Mecklenburg-West Pomerania, the ratio was over 60
percent [5].
Factors affecting the probability of failing to participate
in screening have been shown to include older age,
lower educational status, not owning a car, having no
children and no partner and several other factors [6-10].
In addition, there is evidence for differences in breast
cancer screening participation between migrant and
non-migrant women in several European countries
[8,9,11-13]. For example, Lagerlund et al. [6] show a
lifetime participation of 90 percent among Swedish
women, while participation among migrant women
from non-Scandinavian European countries, South
America and Asia (80 percent), Africa (76 percent) and
North America (73 percent) was lower. A study from
the Netherlands shows a participation of 44 percent
among Turkish migrants (1995–2005) compared to an
overall participation of 79 percent. Older Turkish women
were less likely to participate (40 percent) than younger
Turkish women (50 percent) [14]. Participation among
Turkish migrants increased from 50 percent in 1997–1998
to 62 percent in 2007–2008. This, however, is still much
lower than the overall participation of 80 percent in 1997–
1998 and 83 percent in 2007–2008 [15].
Germany hosts a total of 16 million migrants (for the
purpose of this paper defined as immigrants or their dir-
ect descendants), which is equivalent to more than 19
percent of its population. About 3 million people (more
than 3 percent of the total population and almost 20
percent of the migrant population) residing in Germany
are of Turkish origin. Among the group of Turkish mi-
grants there are about 334,000 women aged 45 to
75 years [16]. In the next decades the proportion of
older (Turkish) migrants will increase considerably [17],
and so will the number and the proportion of migrants
eligible for breast cancer screening.
There is evidence for a lower participation in prevent-
ive measures among migrants in Germany [18]. For ex-
ample, the participation of adult migrants in routine
health examinations is lower than in the majority popu-
lation [19]. To date there are no studies on breast cancer
screening participation among migrants in Germany.
Our research questions are: Does the chance to partici-
pate in breast cancer screening differ between women ofTurkish origin compared to women of non-Turkish ori-
gin? And, is the chance to participate in breast cancer
screening among women of Turkish origin dependent
on their age?
Methods
Data sources
The study is based on routine data from screening units
and population registries. All women participating in the
breast cancer screening program are registered in the
datasets of the screening units responsible for a particu-
lar geographical region (numerator population). These
screening data contain names of participants as well as
year of birth. As in Germany there is no nationwide
database comprising data on participation and migration
status, five screening units from different regions were
chosen (Duisburg, Bielefeld, Paderborn, Hamburg, and
Berlin). We selected “typical” urban screening units to
cover different regions with different proportions of mi-
grants in the population.
To assure data privacy the five screening units were la-
beled as screening unit A-E, not following the order
above. In Germany, women between 50 and 69 years of
age are eligible to attend breast cancer screening every
two years. Data from one 2-year invitation period (2010
and 2011) were included in the study with the aim to
cover all women eligible in this period. Women born in
1940 or 1961 were excluded from the calculation of
screening participation as they lost or gained eligibility
to screening during the 2-year period. For the presenta-
tion of data the age of the women was set as the age in
the first study year (2010). Thus, women born in 1960
were labeled as 50 years old and women born in 1941
were labeled as 69 years old.
To calculate participation ratios, the number of
women living in the catchment areas of each screen-
ing unit was obtained from the population registries
of the 50 cities and villages comprising the catchment
areas of the five screening units (denominator). One
village authority (associated to screening unit E) re-
fused to provide population data for the project and
was therefore also excluded in the screening dataset.
Population data on January 1st 2011 (midterm of the
period) was used.
Identification of women of Turkish origin
Women of Turkish origin were identified in both data-
sets by using a name-based algorithm. As Turkish family
names were introduced by law in the 1930s and had to
have a meaning in the Turkish language, they are thus
highly specific. This method allows identifying women of
Turkish origin in datasets without any other migration-
related variables such as place of birth or nationality
[20-22]. Women with Turkish and non-Turkish first and
Table 1 Number of women in the study and participation
in breast screening among all women, 2010/2011
Number of women
in study (% women
of Turkish origin
in this group)
Overall participation
[%] OR (95% CI)a
Total 423,649 (4.4) 49.2
Screening unit
A 110,845 (6.0) 42.6 Ref
B 67,565 (7.9) 52.0 1.81 (1.78–1.85)*
C 107,707 (3.8) 46.0 1.45 (1.42–1.48)*
D 82,787 (3.8) 57.5 1.14 (1.12–1.17)*
E 98,632 (1.2) 50.8 1.38 (1.36–1.41)*
Age group (years)
50-54 125,006 (3.6) 49.6 Ref
55-59 109,586 (4.0) 50.1 1.02 (1.01–1.04)**
60-64 94,852 (5.8) 50.1 1.03 (1.01–1.05)**
65-69 94,205 (4.5) 46.7 0.91 (0.89–0.92)**
aAn OR >1 means that the chance to participate in breast cancer screening is
higher among all women in the respective category than in the reference category.
*adjusted for age-groups.
**adjusted for screening unit.
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the names to extensive name lists. Ambiguous cases are
flagged and checked manually by a Turkish-speaking re-
searcher and then labeled as Turkish or non-Turkish. The
methodology of the name-based identification has been
described in more detail in previous publications [20,21].
Analysis
The number of women with and without Turkish origin
in each of the screening units was divided by the num-
bers of women with and without Turkish origin in the
respective catchment populations. We calculated odds
ratios to compare the chances of participation among
women of Turkish origin and among women of non-
Turkish origin. At the end of our 2-year study period, all
women had a chance to participate in screening. The
date of participation within the study period is not of
relevance for our purposes; we are interested in com-
paring the chances of participation within a 2-year
screening round. We then compared chances of overall
participation adjusted for age-group and screening unit,
as well as chances of participation for 5-year age-groups
adjusted for screening unit, between women of Turkish
origin and women without Turkish origin. The analyses
were run using Stata 12.0. The study was approved by
the ethical committee of Muenster University.
Results
A total of 208,500 participants in breast cancer screen-
ing were included in the analysis. The automated part of
the name-based algorithm identified 5,978 women with
Turkish names and an additional 5,086 women with
ambiguous names. After the manual check a total of
9,754 participants (4.7 percent of the total participants)
were classified as of Turkish origin and 198,746 as of
non-Turkish origin. Furthermore, 423,649 women in
the eligible age-group living in the catchment areas
of the screening units were included. Of these, 11,143
women were identified as having Turkish names and
9,839 women as having ambiguous names. After the
manual check a total of 18,658 women (4.4 percent
of the total population) in the eligible age group were
classified as of Turkish origin and 404,991 as of non-
Turkish origin.
Table 1 shows participation ratios and odds ratios
stratified by screening unit and 5-year age-groups. About
half of the women in the study areas participated in the
breast cancer screening program. Participation ratios
vary by screening unit from 42.6 percent in screening
unit A to 57.5 percent in screening unit D. The chance
to participate among all women adjusted for age was
1.81 times higher in screening unit B (95% CI: 1.78-1.85)
than in screening unit A (ref ). The analysis by 5-year
age-groups shows that the overall chance to participatein older women aged 65–69 years was marginally lower
(46.7 percent; OR 0.91; 95% CI: 0.89-0.92) than in women
in the other age groups where it was about 50 percent.
There was no change in overall participation ratios when
controlling for migration (data not shown). All regional
and age differences in chance of participation are statisti-
cally significant (Table 1).
The participation ratio was slightly higher in women
of Turkish origin (52.3 percent) than in women of non-
Turkish origin (49.1 percent). The chance in women of
Turkish origin to participate in breast cancer screening
adjusted for age and screening unit was 17 percent higher
compared to women of non-Turkish origin (OR: 1.17; 95%
CI: 1.14-1.21) (Table 2).
Women of Turkish origin, however, showed declining
participation with increasing age (Table 2). This trend
cannot be shown for women of non-Turkish origin.
A higher proportion (47.0 percent) of women without
Turkish origin aged 65–69 years participated in breast
cancer screening than women of Turkish origin of
the same age-group (40.2 percent). Consequently, the
chance for women of Turkish origin aged 65–69 years
to attend screening was lower than for women of non-
Turkish origin (OR: 0.71; 95% CI 0.66-0.75). In the
other age groups the chance to participate was higher
among women of Turkish origin than in women with-
out Turkish origin (Table 2). The chance to participate
was 50 percent higher in women aged 50–54 of Turkish
origin compared to women without Turkish origin
Table 2 Participation in breast screening among women
of Turkish origin compared to women of non-Turkish
origin, 2010/2011
Participation in women
of Turkish origin
OR (95% CI)a
n [%]
Migration (yes vs. no) 9,754 52.3 1.17 (1.14-1.21)*
Age group (years)
50-54 2,658 58.9 1.50 (1.42–1.60)**
55-59 2,564 57.9 1.45 (1.36–1.54)**
60-64 2,844 51.5 1.12 (1.06–1.18)**
65-69 1,688 40.2 0.71 (0.66–0.75)**
aAn OR >1 means that the chance to participate in breast cancer screening is
higher among women of Turkish origin than among women without
Turkish origin.
*adjusted for age-group and screening unit.
**adjusted for screening unit.
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groups were statistically significant.
Discussion
Findings
For the first time, breast cancer screening participation
among women of Turkish origin in Germany was ana-
lysed. Furthermore, our study presents for the first time
data on screening participation in 5-year age-groups
based on routine data. The routine evaluation report of
breast cancer screening in Germany [4] only contains
overall participation ratios. Other studies had to rely on
self-reported screening participation in smaller samples
e.g. [23,24].
Overall, the participation in breast cancer screening
among women of Turkish origin and women of non-
Turkish origin is quite similar. Our study shows that
women of Turkish origin have a slightly higher chance
to participate in breast cancer screening than women of
non-Turkish origin. This finding is unexpected when
taking into consideration that other studies show a
lower participation in preventive measures among mi-
grants in Germany, e.g. a lower participation of adult
migrants in routine health screening tests [19]. Our
results seem also not to be consistent with European
studies showing a lower participation in breast cancer
screening among various migrant groups, compared
to the autochthonous populations [6,11,13]. However,
these studies did not stratify for country of origin, so
they fail to take into account that migrant populations
are heterogeneous.
A reason for the comparatively small differences in
participation ratios among women of Turkish origin and
women of non-Turkish origin in Germany could be that
participation in breast cancer screening is lower inGermany than in some other European countries. For
example, the participation ratio of Turkish immigrant
women in the Netherlands (44–62 percent) [14,15] is ap-
proximately as high as in Germany (40–59 percent).
However, participation among Dutch women is much
higher (79–83 percent) than among all women in Germany
(43–58 percent), thus leading to a larger differential.
Kristiansen and colleagues [13] have shown a decline
in participation among both migrants and the autoch-
thonous Danish population with increasing level of edu-
cation; this decline was higher among migrant women
than among Danish women. There is evidence for dif-
ferences in educational level among migrants compared
to the autochthonous population in Germany. Migrant
women aged 45–65 years more often have no formal
qualification than women of the same age group in the
autochthonous population (more than 15 percent vs.
about 1 percent) [16]. In our study no data on socio-
economic status was available. However, similar studies
from the Netherlands also could not adjust for socio-
economic status; they found lower participation ratios
among women born in Turkey compared to Dutch
women [14,15].
For women of Turkish origin participation ratio was
higher the younger they were. This is in line with findings
from Visser and colleagues from the Netherlands [14].
Turkish immigrant women aged 50 to 54 years showed a
higher participation ratio than older Turkish women.
There was no such tendency among Dutch women, which
is in line with our findings. A possible explanation could
be that older women of Turkish origin more often face
problems with the language of the host country than
younger ones. Another explanation could be differences in
educational levels among women of Turkish origin in dif-
ferent age groups.
Finally, our results confirm a regional variation in
screening participation which is in line with regional
variations in screening participation reported in other
studies in Germany [5] and in the Netherlands [15].
Methodological strengths and limitations
Our study is based on routine data of breast cancer
screening units and thus has a large sample size. Data
quality is good as women attending breast cancer
screening are registered based on name and date of birth
stored on their health insurance card. Administrative
procedures require that all women attending the screen-
ing are registered in the screening datasets. Thus, regis-
tration of participation is complete. Research has shown
that self-reported screening participation is often impre-
cise, especially among migrant populations [25,26]. Our
data, however, do not contain additional information on
factors which might influence screening participation
such as socio-economic status. Thus, our analyses are
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of screening participation.
Our approach leads to somewhat lower estimates of
overall screening participation (49 percent) than the offi-
cial evaluation where a participation of 54 percent was
reported for 2009 [5]. Albert and colleagues [23] found
an even higher participation ratio of 66 percent for
Germany in their (albeit much smaller) sample relying
on self-reported participation. However there is evi-
dence for overestimation when participation in breast
cancer screening is self-reported [26]. One possible
explanation for our lower participation ratios lies in the
regional variability we observed and the fact that the
five screening units we selected may not be representa-
tive of Germany as a whole. Other studies have shown
that participation in breast cancer screening varies
greatly by region. In the federal states of Hamburg a par-
ticipation of 48.1 percent was reported in 2009, while in
Berlin (50.7 percent) and North Rhine-Westfalia (54.3 per-
cent) participation was higher. Variation in participation
is even higher at the level of screening units, ranging
from 35.5 percent to 71.4 percent in 2009 [5]. Participa-
tion in our study ranges from 42.6 percent to 57.5 per-
cent. In addition, migration to a particular place is not
random. In General, migrants tend to settle in urban
areas in former West Germany rather than in rural
areas and former East Germany [27]. Turkish migrant
women in Paderborn might be different from those in
Berlin. We tried to take this possible variability into ac-
count by selecting screening units from different urban
regions with different proportions of Turkish migrant
women in the population.
A second explanation for our lower estimates of
screening participation could be differences in the de-
nominator population. In the official evaluation report
screening participation is calculated based on the num-
ber of women invited. In Germany, 91.6 percent of the
eligible women were invited in 2009 [5]. Using the num-
ber of women invited as the denominator population
was not possible in our study. We had to base our ana-
lyses on the best estimate of the total number of women
(invited and not invited) aged 50–69 years old in the
catchment areas of the screening units.
We chose January 1st, 2011, the middle of the study
period, as reference date for the population data. The
eligible population is not known exactly due to reloca-
tions and death during the study period. We make the
implicit assumption that relocation behavior does not
differ substantially between Turkish and non-Turkish
women aged 50 to 69 years. While it is known that many
older Turkish immigrants stay in Turkey for several
weeks a year, they keep their residency in Germany dur-
ing that time [28] and with that their eligibility for breast
cancer screening.The name-based identification of persons of Turkish
origin is a good method for migrant-sensitive analyses
when no information on migration status is available. The
algorithm used in this study has reached a sensitivity of 85
percent in a previous study with cancer registry data.
The algorithm discriminated well against Greek and
Arab names (1 percent false positive results) [21]. We
could not assess the performance of the algorithm in
our dataset as additional migration variables were miss-
ing. But assessing migration relying on name-based
identification has several limitations. Firstly, a name-
based algorithm can never identify all persons of Turkish
origin in a dataset. For example, women who married a
person with a non-Turkish name will probably not be
identified. However, the proportion of married Turkish
migrant women who married a native German is only 2
percent; 65 percent married a Turkish migrant; and 34
percent are already married at the time of immigration
[29]. Given the small proportion of mixed marriages
this should not bias our findings. Secondly, we compare
Turkish migrant women with the general female po-
pulation of the respective age (excluding, of course,
Turkish migrant women). Our methodology does not
allow comparing Turkish migrant women with autoch-
thonous women alone. This limitation is unlikely to
bias our findings in a substantial way: There are more
than 16 million women aged 45–75 years residing in
Germany, and the number of other migrant women
among them is not very large. For example, the second-
largest subgroup, after Turkish migrant women, are
270,000 women from Poland [16]. Thus, while “other”
migrant women are part of our comparison group, they
constitute only a small proportion and have limited
effect on our estimates.Conclusions
The overall participation ratio in breast cancer screen-
ing of over 70 percent recommended by EU [3] is not
yet reached in Germany. However, our results indicate
that, in contrast to other preventive measures, women
of Turkish origin participate to a higher proportion in
breast cancer screening than women without Turkish
origin. But their participation declines with increasing
age.
Further studies are needed to verify our results as
there are several methodological limitations. Future re-
search should investigate reasons for the possibly higher
screening participation among women of Turkish origin;
the findings might also inform preventive programs in
which participation by migrants is low. Factors affecting
participation among migrant and non-migrant popula-
tions in different age groups need to be studied to ex-
plain possible differences or similarities. Finally, there is
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all participation in screening in Germany.
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